Omnicell Stock Price To Sales
| OMCL Stock | USD 43.20 1.78 3.96% |
Omnicell fundamentals help investors to digest information that contributes to Omnicell's financial success or failures. It also enables traders to predict the movement of Omnicell Stock. The fundamental analysis module provides a way to measure Omnicell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omnicell stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 1.48 | 2.04 |
Omnicell | Price To Sales |
Omnicell Company Price To Sales Analysis
Omnicell's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Omnicell Price To Sales | 1.96 X |
Most of Omnicell's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omnicell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Omnicell Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Omnicell is extremely important. It helps to project a fair market value of Omnicell Stock properly, considering its historical fundamentals such as Price To Sales. Since Omnicell's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Omnicell's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Omnicell's interrelated accounts and indicators.
Click cells to compare fundamentals
Omnicell Price To Sales Historical Pattern
Today, most investors in Omnicell Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Omnicell's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Omnicell price to sales as a starting point in their analysis.
Omnicell Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Omnicell Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Omnicell has a Price To Sales of 1.9576 times. This is 90.85% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 82.86% higher than that of the company.
Omnicell Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omnicell's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omnicell could also be used in its relative valuation, which is a method of valuing Omnicell by comparing valuation metrics of similar companies.Omnicell is currently under evaluation in price to sales category among its peers.
Omnicell ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Omnicell's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Omnicell's managers, analysts, and investors.Environmental | Governance | Social |
Omnicell Fundamentals
| Return On Equity | -0.0146 | ||||
| Return On Asset | -0.0087 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 2.12 B | ||||
| Shares Outstanding | 46.32 M | ||||
| Shares Owned By Insiders | 1.63 % | ||||
| Shares Owned By Institutions | 98.37 % | ||||
| Number Of Shares Shorted | 2.12 M | ||||
| Price To Earning | 64.95 X | ||||
| Price To Book | 1.69 X | ||||
| Price To Sales | 1.96 X | ||||
| Revenue | 1.15 B | ||||
| Gross Profit | 596.71 M | ||||
| EBITDA | (34.87 M) | ||||
| Net Income | (20.37 M) | ||||
| Cash And Equivalents | 244.95 M | ||||
| Cash Per Share | 5.53 X | ||||
| Total Debt | 614.09 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.11 X | ||||
| Book Value Per Share | 26.59 X | ||||
| Cash Flow From Operations | 181.09 M | ||||
| Short Ratio | 2.79 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Price To Earnings To Growth | 2.28 X | ||||
| Target Price | 56.57 | ||||
| Number Of Employees | 3.66 K | ||||
| Beta | 0.82 | ||||
| Market Capitalization | 2.08 B | ||||
| Total Asset | 2.23 B | ||||
| Retained Earnings | 370.36 M | ||||
| Working Capital | 559.78 M | ||||
| Current Asset | 50.15 M | ||||
| Current Liabilities | 50.17 M | ||||
| Net Asset | 2.23 B |
About Omnicell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omnicell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omnicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omnicell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Omnicell Piotroski F Score and Omnicell Altman Z Score analysis. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.558 | Earnings Share (0.39) | Revenue Per Share 23.218 | Quarterly Revenue Growth (0.05) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.